Kyle Wright
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immune Cell Function and Interaction
- Immunodeficiency and Autoimmune Disorders
- Immunotherapy and Immune Responses
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
-
- Inflammasome and immune disorders 2
- Co-authors
- Scott J. Rodig (5 shared papers)Philippe Armand (4 shared papers)Reid W. Merryman (1 shared paper)Anthony T. Vella (4 shared papers)Jason L. Weirather (3 shared papers)Caron A. Jacobson (2 shared papers)John M. Rossi (2 shared papers)Julie Ng (2 shared papers)
- Journals
- Blood Advances (3 papers)Blood (2 papers)Infection and Immunity (1 paper)The Journal of Immunology (1 paper)Blood Cells Molecules and Diseases (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Kyle Wright
19 papers receiving 384 citations
Peers
Comparison fields: 5 of 56
- Oncology 175
- Immunology 128
- Periodontics 19
- Pathology and Forensic Medicine 73
- Genetics 21
Countries citing papers authored by Kyle Wright
This map shows the geographic impact of Kyle Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Wright more than expected).
Fields of papers citing papers by Kyle Wright
This network shows the impact of papers produced by Kyle Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Wright. The network helps show where Kyle Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 82 | |
| 2 | 2020 | 68 | |
| 3 | 2013 | 67 | |
| 4 | 2017 | 32 | |
| 5 | 2019 | 25 | |
| 6 | 2013 | 24 | |
| 7 | Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study. | 2000 | 23 |
| 8 | 2023 | 20 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 5 | |
| 12 | 2014 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2018 | 4 | |
| 15 | 2019 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2020 | 1 | |
| 19 | Interrogating Raf-1 Kinase Inhibitor Protein (RKIP) as a Novel Therapeutic Target for Modulating Inflammatory Responses | 2016 | 1 |
| 20 | 2023 | 0 |
About Kyle Wright
Kyle Wright is a scholar working on Oncology, Molecular Biology, Immunology, Pathology and Forensic Medicine and Epidemiology, having authored 22 papers that have together received 386 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Fungal Infections and Studies (2 papers), Inflammasome and immune disorders (2 papers), Immune Response and Inflammation (2 papers) and Silicon Carbide Semiconductor Technologies (1 paper). The work is most often cited by research in Oncology (175 citations), Immunology (128 citations), Periodontics (19 citations), Pathology and Forensic Medicine (73 citations) and Genetics (21 citations). Kyle Wright has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Scott J. Rodig, Philippe Armand, Reid W. Merryman, Anthony T. Vella, Jason L. Weirather, Caron A. Jacobson, John M. Rossi, Julie Ng, Zachary Roberts and Mikel Lipschitz. Their work appears in journals such as Blood Advances, Blood, Infection and Immunity, The Journal of Immunology and Blood Cells Molecules and Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.